Uterine fibroids are the most common benign tumors of the female reproductive system, with an incidence of 30% to 50% in women of childbearing age. Although most patients with uterine fibroids have small fibroids, some patients with large fibroids and multiple fibroids still have obvious clinical symptoms, which cause great physical and psychological damage to patients. Therefore, active treatment is still needed for some patients with fibroids who have symptoms such as excessive menstruation, anemia, lower abdominal distension, back pain, and infertility. In the past, the treatment of uterine fibroids was mainly surgical, and some patients even needed to have their uterus removed, making the patients lose their chance to have children. Interventional therapy is a minimally invasive treatment for fibroids that has emerged in recent years and is valued and respected by the world’s medical community for its ability to cure fibroids without damaging the uterus. Interventional treatment of uterine fibroids has the following advantages: 1. Small trauma, low risk, no surgical scars: Interventional treatment only requires puncturing the femoral artery at the root of the thigh, and then super-selective embolization of the uterine artery using a 1,5mm catheter, leaving only a small incision of about 1~2mm after treatment. Therefore, the trauma is very small, the risk is very low, and there is no scar after the operation, which is more suitable for patients with high cosmetic requirements. 2, the uterus can be preserved, so fertility may be preserved: because the principle of interventional therapy is to embolize the uterine artery, resulting in rapid necrosis and atrophy of the fibroid, while the normal uterus does not undergo necrosis due to good tolerance to hypoxia, and will gradually restore blood supply and function. Therefore, embolization of fibroids is an ideal option for women who want to preserve their uterus and fertility. Although there is theoretically some effect on fertility due to embolization of the uterine artery and a certain degree of radiation received by the patient, studies abroad in recent years have generally concluded that the effect is not significant. 3, the treatment of multiple myomas is better: some patients can have as many as several or even dozens of myomas, and the possibility of surgical cure is very small in such patients without removing the uterus. This is not the case with interventional therapy, as long as the catheter is in place and the embolization agent is in place, it is effective for all fibroids, regardless of the number of fibroids. Therefore, interventional treatment has greater advantages for multiple tumors. 4. Less pain: The pain is more obvious after interventional treatment of uterine fibroids in the early stage, which is mainly due to the poor catheter superselection technology in the early stage and the embolic agent is mostly iodine oil + pinyamycin which is more irritating. The use of uterine artery catheter and microcatheter developed nowadays makes uterine artery superselection simpler and in place, and the embolic agent has been changed to a less irritating embolic agent, and pain medication is routinely taken before and after surgery, so we rarely encounter patients with significant pain. The pain is much less than surgical treatment and less than other minimally invasive treatments such as laser, microwave and radiofrequency. Interventional treatment of fibroids has become a popular treatment method worldwide. Within a few years, half of the patients with fibroids in the United States have opted for interventional treatment, and Ms. Rice, the former U.S. Secretary of State, was also a fibroid patient who eventually chose interventional treatment and cured her disease. Therefore, interventional treatment of fibroids is undoubtedly the best choice for some female patients who are afraid of surgery and worried about fibroids.